Study identifier:D5980R00042
ClinicalTrials.gov identifier:NCT04928417
EudraCT identifier:N/A
CTIS identifier:N/A
Exacerbations and their Outcomes International (EXACOS International): Understanding burden of severe exacerbations of COPD and association between frequency of severe exacerbations clinical and health-care utilization outcomes in less well-resourced countries
Chronic Obstructive Pulmonary Disease
N/A
No
-
All
1762
Observational
40 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Oct 2023 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|